The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK's FTSE 100 hits record high on BP boost, less-hawkish Powell

Wed, 08th Feb 2023 17:26

BP touches 3-year high

*

Smurfit Kappa slides as results disappoint

*

UK Q4 GDP to be released on Friday

*

FTSE 100 up 0.3%, FTSE 250 adds 0.6%

Feb 8 (Reuters) - Britain's blue-chip FTSE 100 index briefly hit a record high on Wednesday, boosted by gains in oil major BP, while investors drew comfort from less hawkish than feared remarks by Federal Reserve Chair Jerome Powell.

The exporter-heavy FTSE 100 rose 0.3% at close after hitting an all-time high of 7,934.30 in intraday trading, surpassing its previous peak of 7,906.58 hit last week. The midcap FTSE 250 index climbed 0.6%.

Shares of BP rose 3.3% to a more than three-year high, extending gains after the British energy giant on Tuesday reported record profit for 2022.

Drugmaker AstraZeneca climbed 1.6% ahead of its quarterly results on Thursday.

Equities rallied after Powell said on Tuesday 2023 should be a year of "significant declines in inflation" even as he acknowledged that rates may need to move higher than expected if economic strength threatens the Fed's progress in lowering inflation.

"He (Powell) didn't put much weight on the argument that inflation has peaked," said Stuart Cole, head macro economist at Equiti Capital.

"That gave the market some confidence that the FOMC is on board and thinking that the worst of the inflation forces have now gone."

Back home, investors will keep a close eye on the UK gross domestic product (GDP) data due to be published on Friday, with the preliminary reading expected to show the British economy contracted 0.3% last December, but likely avoided a technical recession in the fourth quarter.

Meanwhile, the National Institute for Economic and Social Research (NIESR) cut its forecast for UK GDP growth this year to 0.2% from 0.7%, saying Britain will dodge recession in 2023 but its people will face the after-effects of a severe fall in living standards.

Smurfit Kappa fell 3.3% after the packaging giant said box volumes were down less than 2% in 2022 against a strong prior year, and that Germany and the UK markets performed below expectations.

Peers DS Smith and Mondi lost more than 2% each. (Reporting by Sruthi Shankar and Shashwat Chauhan in Bengaluru; Editing by Savio D'Souza, Sherry Jacob-Phillips and Emelia Sithole-Matarise)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.